PrintPrint

China Pharmaceutical Market Report 2010

By Ames Gross

Published by Pacific Bridge Medical

January 2010

Price: $600

25% off! Now $450

Buy Report

Overview:

China's pharmaceutical market is not only a large, rising opportunity in itself – reaching an estimated $37 billion in 2008 and still growing at near 20% annually – in the near future, it will also join the world's biggest pharmaceutical markets. This makes it strategically crucial for Western pharmaceutical companies to succeed there. However, the Chinese drug market has unique characteristics which must be understood to make the China potential a reality.

This research report contains key information on multiple important topics of the Chinese pharmaceutical market, including market data, the role of government health insurance reimbursement, government price controls, institutional purchasing practices, differing characteristics and business strategies of domestic and foreign pharmaceutical companies, and more. It also includes three appendices: one on recent acquisitions, ventures, and partnerships in the Chinese drug industry; a list of all drugs which Chinese government health insurance will reimburse; and contact information for key Chinese drug agencies.

This report is 36 pages. The appendices are an additional 26 pages.

Fully updated for 2010 with new statistics.

See a sample page of this report.

Table of Contents

  1. Introduction to China
  2. Overview of China Pharmaceutical Market
    1. China Healthcare System
    2. Growth in Healthcare Spending
    3. Pharmaceutical Sales
  3. Health Insurance in China
    1. Overview
    2. Basic Medical Insurance
    3. Other Public Health Insurance Systems
    4. Private Health Insurance
  4. Drug Reimbursement System
    1. Mechanics of Drug Reimbursement
    2. Drug Reimbursement List
    3. Who Controls Revisions to Drug Reimbursement Lists
    4. When Reimbursement is Important
    5. Strategies for Reimbursement List Entry
  5. Price Determination
  6. Hospital Purchasing and Prescribing
    1. Hospital Tendering
    2. Prescription Controls
  7. Foreign Pharmaceutical Companies in China
    1. Overview
    2. Trends
  8. Domestic Chinese Pharmaceutical Companies
    1. Overview
    2. Domestic Pharmaceutical Companies' Changing Strategies
  9. Pharmaceutical Distribution in China
  10. Predicted Trends
    1. Overview
    2. Healthcare Providers
    3. Healthcare Funding
    4. Reimbursement System
    5. Price Determination
    6. Regulatory Approvals
  11. Conclusion

Appendices:

Appendix A: Recent Acquisitions, Ventures, and Partnerships in the Chinese Drug Industry
Appendix B: National Reimbursement Drug List
Appendix C: Key Drug Agencies in China

Order now and we will ship you this report at no additional charge.

Price: $600

Please contact us at researchstore@pacificbridgemedical.com if you have any questions.

Buy Report

Back to top